ÂÜÀòÂÒÂ×

Marc Schegerin is the current Chief Financial Officer, Head of Strategy and Treasurer at ArQule. Prior to this, they were with Morphic Therapeutic as their Chief Financial Officer, Head of Strategy & Treasurer. Before that, they were a Director at Citi Healthcare Investment Banking and prior to that they were a Vice President Investment Banking at Bank of America Merrill Lynch. Marc has also worked as the Senior Director at Sage Therapeutics and as a Program Director at Biogen Idec.

Marc Schegerin has a MD from the Geisel School of Medicine at Dartmouth, an MBA from The Tuck School of Business at Dartmouth, and a BS in Management from Tulane University - A.B. Freeman School of Business. Marc did their premedical studies in Physics at Harvard University.

Marc Schegerin reports to Paolo Pucci, CEO. They are on a team with Peter S. Lawrence - President and Chief Operating Officer, Brian Schwartz - Chief Medical Officer.